PT86819A - Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same - Google Patents

Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same

Info

Publication number
PT86819A
PT86819A PT86819A PT8681988A PT86819A PT 86819 A PT86819 A PT 86819A PT 86819 A PT86819 A PT 86819A PT 8681988 A PT8681988 A PT 8681988A PT 86819 A PT86819 A PT 86819A
Authority
PT
Portugal
Prior art keywords
preparation
same
pharmaceutical compositions
compositions containing
insulin derivatives
Prior art date
Application number
PT86819A
Other languages
English (en)
Other versions
PT86819B (pt
Inventor
Liselotte Langkjaer
Kjeld Norris
Jan Markussen
Klavs Holger Jorgensen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27221014&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT86819(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DK94887A external-priority patent/DK94887D0/da
Priority claimed from DK356987A external-priority patent/DK356987D0/da
Priority claimed from DK540087A external-priority patent/DK157901C/da
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of PT86819A publication Critical patent/PT86819A/pt
Publication of PT86819B publication Critical patent/PT86819B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT86819A 1987-02-25 1988-02-24 Processo para a preparacao de novos derivados da insulina e de composicoes farmaceuticas que os contem PT86819B (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK94887A DK94887D0 (da) 1987-02-25 1987-02-25 Praeparat med fordelagtige egenskaber
DK356987A DK356987D0 (pt) 1987-07-10 1987-07-10
DK540087A DK157901C (da) 1986-10-20 1987-10-16 Insulinpraeparat til parenteral administration indeholdende magnesiumioner

Publications (2)

Publication Number Publication Date
PT86819A true PT86819A (pt) 1988-03-01
PT86819B PT86819B (pt) 1992-05-29

Family

ID=27221014

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86819A PT86819B (pt) 1987-02-25 1988-02-24 Processo para a preparacao de novos derivados da insulina e de composicoes farmaceuticas que os contem

Country Status (12)

Country Link
EP (1) EP0280534B1 (pt)
JP (1) JP2606915B2 (pt)
AU (1) AU612141B2 (pt)
CA (1) CA1339416C (pt)
DE (2) DE10075034I1 (pt)
ES (1) ES2053723T3 (pt)
FI (1) FI884914L (pt)
IE (1) IE62879B1 (pt)
NL (1) NL300029I1 (pt)
NZ (1) NZ223630A (pt)
PT (1) PT86819B (pt)
WO (1) WO1988006599A1 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK257988D0 (da) * 1988-05-11 1988-05-11 Novo Industri As Nye peptider
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
JPH04502465A (ja) * 1988-12-23 1992-05-07 ノボ　ノルディスク　アクティーゼルスカブ ヒトインシュリン類似物質
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
ZA924448B (en) * 1991-06-21 1993-12-17 Lilly Co Eli Insulin Analogs
US6869930B1 (en) 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
AU1272295A (en) * 1993-12-17 1995-07-03 Novo Nordisk A/S Proinsulin-like compounds
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
AUPP609198A0 (en) * 1998-09-22 1998-10-15 Curtin University Of Technology Use of non-peptidyl compounds for the treatment of insulin related ailments
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
AU2002342597A1 (en) 2001-11-19 2003-06-10 Novo Nordisk A/S Process for preparing insulin compounds
GB0206792D0 (en) 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
RU2381103C2 (ru) 2003-06-27 2010-02-10 Ново Нордиск А/С Контейнер для жидких фармацевтических композиций с высокими влагозащитными свойствами
DE602004029496D1 (de) 2003-12-22 2010-11-18 Novo Nordisk As Offbehälter zur lagerung von pharmazeutischen flüssigkeiten
EP1708755B1 (en) 2004-01-21 2012-03-21 Novo Nordisk Health Care AG Transglutaminase mediated conjugation of peptides
ES2391776T3 (es) 2004-11-22 2012-11-29 Novo Nordisk A/S Formulaciones solubles, estables conteniendo insulina con una sal de protamina
WO2008049711A1 (en) 2006-10-27 2008-05-02 Novo Nordisk A/S Peptide extended insulins
JP2010525033A (ja) * 2007-04-30 2010-07-22 ノボ・ノルデイスク・エー／エス 高濃縮のインスリン溶液及び組成物
WO2009087082A2 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil
JP5694779B2 (ja) 2008-01-09 2015-04-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
TWI451876B (zh) 2008-06-13 2014-09-11 Lilly Co Eli 聚乙二醇化之離脯胰島素化合物
WO2010016069A1 (en) 2008-08-07 2010-02-11 Biocon Limited A process for preparation of insulin compounds
LT3228320T (lt) 2008-10-17 2020-03-10 Sanofi-Aventis Deutschland Gmbh Insulino ir glp-1 agonisto derinys
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
FR2943538B1 (fr) 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
EP2498801B1 (de) 2009-11-13 2018-01-24 Sanofi-Aventis Deutschland GmbH HARMAZEUTISCHE ZUSAMMENSETZUNG UMFASSEND desPro36Exendin-4(1-39)-Lys6-NH2 UND METHIONIN
PL2498802T3 (pl) 2009-11-13 2015-06-30 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
EP2460527A1 (en) 2010-01-21 2012-06-06 Sanofi Pharmaceutical composition for treating a metabolic syndrome
AR080884A1 (es) 2010-04-14 2012-05-16 Sanofi Aventis Conjugados de insulina-sirna
SI2611458T1 (sl) 2010-08-30 2017-01-31 Sanofi-Aventis Deutschland Gmbh Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
EP2548570A1 (en) 2011-07-19 2013-01-23 Sanofi Pharmaceutical composition for treating a metabolic syndrome
HUE027989T2 (en) 2011-08-29 2016-11-28 Sanofi Aventis Deutschland A pharmaceutical composition for use in glycemic control in patients with type 2 diabetes
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
CN104902922B (zh) 2012-11-13 2017-12-12 阿道恰公司 包含经取代阴离子化合物的速效胰岛素制剂
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
WO2015196174A1 (en) 2014-06-20 2015-12-23 Greene Howard E Infusion delivery devices and methods
CA2970200A1 (en) 2014-12-12 2016-06-16 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
AR102869A1 (es) 2014-12-16 2017-03-29 Lilly Co Eli Composiciones de insulina de rápida acción
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
BR112019022212A2 (pt) 2017-06-01 2020-05-12 Eli Lilly And Company Composições de insulina de ação rápida
EP3915571A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action
EP3915572A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364116A (en) * 1964-11-02 1968-01-16 Squibb & Sons Inc Method of use of desalanino insulin compositions
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product
DE2252157C3 (de) * 1972-10-25 1976-03-18 Hoechst Ag Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten
NL7314766A (pt) * 1972-10-31 1974-05-02
DE2253327A1 (de) * 1972-10-31 1974-05-09 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
ZW17482A1 (en) * 1981-08-27 1982-11-17 Lilly Co Eli Pharmaceutical formulations comprising human insulin and human c-peptide
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation

Also Published As

Publication number Publication date
JPH01502434A (ja) 1989-08-24
CA1339416C (en) 1997-09-02
IE880499L (en) 1988-08-25
DE10075034I1 (de) 2001-05-23
DE3880346T2 (de) 1993-07-29
DE3880346D1 (de) 1993-05-27
EP0280534A2 (en) 1988-08-31
JP2606915B2 (ja) 1997-05-07
FI884914A7 (fi) 1988-10-24
WO1988006599A1 (en) 1988-09-07
PT86819B (pt) 1992-05-29
EP0280534B1 (en) 1993-04-21
NZ223630A (en) 1989-11-28
EP0280534A3 (en) 1990-01-31
NL300029I1 (nl) 2001-02-01
FI884914A0 (fi) 1988-10-24
FI884914L (fi) 1988-10-24
AU1397688A (en) 1988-09-26
IE62879B1 (en) 1995-03-08
AU612141B2 (en) 1991-07-04
ES2053723T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
HU896032D0 (en) Process for the preparation of novel quinuc lidine derivatives and pharmaceutical compositions containing them
PT84860A (en) Process for the preparation of novel tetrahydronaphtalene derivatives and of pharmaceutical compositions containing the same
PT84936A (en) Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same
PT85071A (en) Process for the preparation of derivatives of fused cyclic azepin-2-ones and of pharmaceutical compositions containing the same
PT87237A (pt) Process for the preparation of bifunctional proteins and of pharmaceutical compounds containing them
PT84790B (pt) Processo de preparacao de derivados de amino-tiazol e de amino-oxazole e de composicoes farmaceuticas contendo-os
PT82985A (pt) Process for the preparation of distamycin derivatives and of pharmaceutical compositions containing the same
PT86516A (en) Process for the preparation of heteroaryl-3-oxo-propani-nitrile derivatives and of pharmaceutical compositions containing the same
PT86365A (en) Process for the preparation of pyridazodiazepine derivatives and of pharmaceutical compositions containing the same
PT87470A (pt) Process for the preparation of novel substituted benzamides and of pharmaceutical compositions containing the same
PT87111A (pt) Process for the preparation of cyclic peptides and of pharmaceutical compositions containing the same
PT86407A (en) Process for the preparation of new alkanesulfonanilide derivatives and pharmaceutical compositions comprising the same
PT82984A (en) Process for the preparation of poly-4-aminopyrrole-2-carboxamido derivatives and of pharmaceutical compositions containing the same
PT84358A (en) Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same
HU896479D0 (en) Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof
HU896612D0 (en) Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof
PT87699A (pt) Process for the preparation of tricyclic pyridone derivatives and of pharmaceutical compositions containing the same
PT87243A (pt) Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
PT85337A (en) Process for the preparation of cycloalkyl-substituted 4-pyridil derivatives and of pharmaceutical compositions containing the same
PT86874A (pt) Process for the preparation of cromona by products and of pharmaceutical compounds containing them
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
PT87202A (pt) Process for the preparation of novel acyl derivatives and of pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19911128

PD3A Change of proprietorship
MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080224